NEO

#1894
NeoGenomics, Inc. - Common Stock
10.5 2 USD
+3.14%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
10.52
10.52
Range Annuel
4.72
13.74
Changement quotidien
+3.14%
Changement Mensuel
+16.11%
Evolution sur 6 mois
-12.33%
Changement Annuel
+42.93%
Clôture Précédente
10.2 0
Open
10.5 2
Low
10.5 2
High
10.5 2
Volume
154
Afficher le graphique complet Full chart

Financials

Aperçu Relevé Statistiques
Trimestriel Annuel
Compte de résultat Bilan Flux de trésorerie
Valeur Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM

NeoGenomics, Inc. - Common Stock

NeoGenomics Laboratories, Inc., also known as NeoGenomics or Neo, is an American CLIA-certified clinical laboratory, pharma services and information services company that specializes in cancer genetics diagnostic testing. The company's testing services include cytogenetics, fluorescence in situ hybridization, flow cytometry, immunohistochemistry, anatomic pathology, and molecular genetics. Headquartered in Fort Myers, FL, NeoGenomics maintains a network of testing facilities across the US, with laboratories in Florida, California, Tennessee, and Texas.

Nouvelles